Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Promoting repair in multiple sclerosis: problems and prospects.

Catherine Lubetzki1, Anna Williams, Bruno Stankoff

  • 1Fédération de Neurologie, Hôpital de la Salpêtrière, Université Pierre et Marie Curie, Paris, France. catherine.lubetzki@psl.ap-hop-paris.fr

Current Opinion in Neurology
|May 14, 2005
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Engaging With Children: Why We Must Continue to Learn From Every Study We Undertake.

Qualitative health research·2026
Same author

Challenges and future directions for multiple sclerosis after the 2024 McDonald diagnostic criteria.

Nature medicine·2026
Same author

Magnetoencephalography biomarkers for assessing myelin content and neuronal function in acute optic neuritis.

Brain communications·2026
Same author

Bispecific antibody therapy in multiple myeloma and risk of progressive multifocal leukoencephalopathy.

Blood advances·2026
Same author

Cell-type- and state-resolved transcriptomics uncovers distinct T cell and monocyte dysregulation in multiple sclerosis.

Cell reports·2026
Same author

French NOMADMUS Cohort Overview: Landscape Evolution of AQP4+NMOSD and MOGAD From 2010 to 2024.

Neurology·2026

Current multiple sclerosis treatments do not halt disability progression. Research focuses on tissue repair strategies like remyelination and neuroprotection, but clinical success remains elusive.

Area of Science:

  • Neuroscience
  • Regenerative Medicine
  • Clinical Neurology

Background:

  • Multiple sclerosis (MS) therapies primarily target inflammation, with limited impact on disability progression linked to myelin and axon injury.
  • Understanding tissue injury mechanisms and developing repair strategies are critical for MS management.
  • Current research explores enhancing endogenous repair and grafting exogenous cells for remyelination.

Purpose of the Study:

  • To review recent breakthroughs in myelin and axon repair mechanisms in multiple sclerosis.
  • To discuss the potential therapeutic applications of novel remyelination and neuroprotection strategies.
  • To highlight challenges in translating basic science findings into clinical treatments for MS.

Main Methods:

  • Literature review of recent scientific advancements in MS tissue repair.

Related Experiment Videos

  • Analysis of hypotheses explaining remyelination failure in MS.
  • Evaluation of emerging neuroprotective strategies and cell-based therapies.

    • Main Results:

    • Potential remyelination strategies include enhancing endogenous repair with neurotrophic factors or using exogenous cells.
    • Neuroprotective agents like statins and modulation of excitotoxicity show promise in preclinical models.
    • Despite numerous targets, no remyelination or neuroprotection treatments have shown clinical efficacy in humans.

    Conclusions:

    • Translating basic science discoveries into effective MS therapies requires addressing challenges in efficacy assessment and delivery.
    • Improving tolerance and delivery of neurotrophic factors is crucial for successful remyelination.
    • Defining indications and limitations for cell transplantation is necessary for clinical application.